Other News To Note
Wednesday, June 20, 2012
Coronado Biosciences Inc., of Burlington, Mass., reported that the FDA granted orphan drug status to its biologic CNDO-109 for the treatment of acute myeloid leukemia (AML).
Sign up for Perspectives FREE e-mail newsletter.
Outside the U.S.: 1-404-262-5423
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.